
Canada - TSX Venture Exchange - TSX-V:QIPT - CA74880P1045 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to QIPT.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-17 | Raymond James Capital | Upgrade | Outperform |
| 2022-04-28 | Raymond James Capital | Initiate | Outperform |
| 2022-03-24 | Colliers Securities | Initiate | Buy |
| 2022-02-16 | Raymond James Capital | Initiate | Outperform |
| 2022-01-31 | Raymond James Financial | Initiate | Outperform |
| 2021-12-20 | Canaccord Genuity | Downgrade | Buy |
| 2021-12-17 | Raymond James Financial | Initiate | Outperform |
| 2021-11-24 | RaymondJamesFinancial | Initiate | Outperform |
| 2021-11-19 | CanaccordFinancial | Upgrade | Buy |
| 2021-08-25 | Raymond James Financial | Initiate | Outperform |
| 2021-06-02 | Raymond James Financial | Initiate | Outperform |
The consensus rating for QUIPT HOME MEDICAL CORP (QIPT.CA) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering QUIPT HOME MEDICAL CORP (QIPT.CA) is 13.